Ethics approval and consent to participate
The study described herein is part of a minimal risk protocol registered with ClinicalTrials.gov (NCT03457415), reviewed and approved by the Sterling Institutional Review Board (Atlanta, GA), and conducted according to ethical principles of the Declaration of Helsinki (v 1996) and Good Clinical Practice guidelines. Participants were enrolled in the study upon signing a written consent after the study was explained to them by a study coordinator.